Description
An antiparkinsonian agent. A non-ergoline selective agonist of dopamine D2 and D3 receptors. A possible mechanism of action in the treatment of Parkinson’s disease , associated with a stimulating effect on the postsynaptic D2 receptors of the basal nuclei in the brain.
Reviews
There are no reviews yet.